Skip to content
Home/Companies/Biotech/InSphero
InSphero

InSphero

Biotech·Switzerland·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns InSphero?

InSphero is a Swiss Biotech company, currently owned by ZEISS Ventures since 2023.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
ZEISS Ventures
Investor
ZEISS Ventures
ZEISS Ventures CVC · 2019 · Evergreen

Key facts

HQSwitzerland
SectorBiotech
StatusActive
Websiteinsphero.com

More from ZEISS Ventures CVC

Other portfolio companies in the same fund.

Custom Surgical
Custom Surgical
Active
MedTechGermany· 2026
Maculaser
Active
MedTechFinland· 2026
arcoris bio
Active
BiotechSwitzerland· 2025
Lidrotec
Active
Deep TechGermany· 2025
Odne
Active
MedTechSwitzerland· 2025
Surgify Medical
Active
MedTechFinland· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns InSphero?

InSphero is currently owned by ZEISS Ventures, through ZEISS Ventures CVC, since 2023.

When did ZEISS Ventures acquire InSphero?

ZEISS Ventures acquired InSphero in 2023.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue